Feasibility and accuracy evaluation of three human papillomavirus assays for FTA card-based sampling: A pilot study in cervical cancer screening

BMC Cancer

Volumn 15, Issue 1, 2015, Pages

  Wang, Shao Ming ^a   Hu, Shang Ying ^a   Chen, Wen ^a   Chen, Feng ^a   Zhao, Fang Hui ^a   He, Wei ^a   Ma, Xin Ming ^a   Zhang, Yu Qing ^a   Wang, Jian ^a,b   Sivasubramaniam, Priya ^a,c   Qiao, You Lin ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b Beijing Municipal Institute of Labour Protection   (China)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

careHPV ; Cervical cancer screening; Cobas 4800; Hybrid capture 2 (HC2); Whatman Indicating FTA Elute card (FTA card)

Indexed keywords

ADULT; AGED; ANALYTICAL EQUIPMENT; ARTICLE; CANCER SCREENING; COLPOSCOPY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEASIBILITY STUDY; FEMALE; FTA CARD; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; HUMAN TISSUE; MAJOR CLINICAL STUDY; PILOT STUDY; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; CERVICAL INTRAEPITHELIAL NEOPLASIA; CLINICAL TRIAL; EARLY CANCER DIAGNOSIS; GENETICS; GENOTYPE; MIDDLE AGED; MULTICENTER STUDY; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROCEDURES; REPRODUCIBILITY; UTERINE CERVICAL NEOPLASMS; VAGINA SMEAR; VIROLOGY;

VIRUS DNA;

ADULT; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; EARLY DETECTION OF CANCER; FEASIBILITY STUDIES; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PILOT PROJECTS; REPRODUCIBILITY OF RESULTS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84953636705     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/s12885-015-1882-9     Document Type: Article

References (22)

1. Bray F, Ren JS, Masuyer E, Ferlay J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 2013;132:1133-45.
2. Ferlay J SI, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, et al. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; Available from: http://globocan.iarc.fr , accessed on 15/01/2015.
3. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12-9.
4. Cuzick J, Arbyn M, Sankaranarayanan R, Tsu V, Ronco G, Mayrand MH, et al. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine. 2008;26 Suppl 10:K29-41.
5. Guan Y, Gravitt PE, Howard R, Eby YJ, Wang S, Li B, et al. Agreement for HPV genotyping detection between self-collected specimens on a FTA cartridge and clinician-collected specimens. J Virol Methods. 2013;189:167-71.
6. Guan Y, Castle PE, Wang S, Li B, Feng C, Ci P, et al. A cross-sectional study on the acceptability of self-collection for HPV testing among women in rural China. Sex Transm Infect. 2012;88:490-4.
7. Gustavsson I, Lindell M, Wilander E, Strand A, Gyllensten U. Use of FTA card for dry collection, transportation and storage of cervical cell specimen to detect high-risk HPV. J Clin Virol. 2009;46:112-6.
8. Gustavsson I, Sanner K, Lindell M, Strand A, Olovsson M, Wikstrom I, et al. Type-specific detection of high-risk human papillomavirus (HPV) in self-sampled cervicovaginal cells applied to FTA elute cartridge. J Clin Virol. 2011;51:255-8.
9. Lenselink CH, de Bie RP, van Hamont D, Bakkers JM, Quint WG, Massuger LF, et al. Detection and genotyping of human papillomavirus in self-obtained cervicovaginal samples by using the FTA cartridge: new possibilities for cervical cancer screening. J Clin Microbiol. 2009;47:2564-70.
10. de Bie RP, Schmeink CE, Bakkers JM, Snijders PJ, Quint WG, Massuger LF, et al. The indicating FTA elute cartridge a solid sample carrier to detect high-risk HPV and high-grade cervical lesions. J Mol Diagn. 2011;13:371-6.
11. Geraets DT, van Baars R, Alonso I, Ordi J, Torne A, Melchers WJ, et al. Clinical evaluation of high-risk HPV detection on self-samples using the indicating FTA-elute solid-carrier cartridge. J Clin Virol. 2013;57:125-9.
12. Gonzalez P, Cortes B, Quint W, Kreimer AR, Porras C, Rodriguez AC, et al. Evaluation of the FTA carrier device for human papillomavirus testing in developing countries. J Clin Microbiol. 2012;50:3870-6.
13. Qiao YL, Jeronimo J, Zhao FH, Schweizer J, Chen W, Valdez M, et al. Lower cost strategies for triage of human papillomavirus DNA-positive women. Int J Cancer. 2014;134:2891-901.
14. Zhao FH, Jeronimo J, Qiao YL, Schweizer J, Chen W, Valdez M, et al. An evaluation of novel, lower-cost molecular screening tests for human papillomavirus in rural China. Cancer Prev Res. 2013;6:938-48.
15. Pretorius RG, Zhang WH, Belinson JL, Huang MN, Wu LY, Zhang X, et al. Colposcopically directed biopsy, random cervical biopsy, and endocervical curettage in the diagnosis of cervical intraepithelial neoplasia II or worse. Am J Obstet Gynecol. 2004;191:430-4.
16. Qiao YL, Sellors JW, Eder PS, Bao YP, Lim JM, Zhao FH, et al. A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol. 2008;9:929-36.
17. Heideman DA, Hesselink AT, Berkhof J, van Kemenade F, Melchers WJ, Daalmeijer NF, et al. Clinical validation of the cobas 4800 HPV test for cervical screening purposes. J Clin Microbiol. 2011;49:3983-5.
18. Castle PE, Sadorra M, Lau T, Aldrich C, Garcia FA, Kornegay J. Evaluation of a prototype real-time PCR assay for carcinogenic human papillomavirus (HPV) detection and simultaneous HPV genotype 16 (HPV16) and HPV18 genotyping. J Clin Microbiol. 2009;47:3344-7.
19. Li J, Fine J. On sample size for sensitivity and specificity in prospective diagnostic accuracy studies. Stat Med. 2004;23:2537-50.
20. Zhao FH, Lin MJ, Chen F, Hu SY, Zhang R, Belinson JL, et al. Performance of high-risk human papillomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient data from 17 population-based studies from China. Lancet Oncol. 2010;11:1160-71.
21. Chen W, Yu LL, Wang H, Fu CJ, Chen F, Cao YQ, et al. Evaluation of cobas 4800 high-risk HPV test as a tool in cervical cancer screening and cytology triage. Zhonghua Zhong Liu Za Zhi. 2012;34:543-8.
22. Phongsavan K, Gustavsson I, Marions L, Phengsavanh A, Wahlstrom R, Gyllensten U. Detection of human papillomavirus among women in Laos: feasibility of using filter paper card and prevalence of high-risk types. Int J Gynecol Cancer. 2012;22:1398-406.